Keywords: gsk, results, slightly, below, consensus, forecasts, glaxosmithkline
GSK's 2003 results slightly below consensus forecasts
Article | 16 February 2004
GlaxoSmithKline, Europe's largest drugmaker, has delivered full-year 2003 business performance earnings per share growth of 10%, in line with its own expectations ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
